Abstract: Disclosed are an image encoding/decoding method and apparatus. The image decoding method includes decoding coding mode information of a current coding block, dividing the current coding block into at least one prediction block, and generating prediction samples of the at least one prediction block on the basis of the decoded coding mode, in which the coding mode information is information indicating any one mode among intra mode, inter mode, and hybrid mode.

Abstract: An instrument and method for collecting and harvesting gingival crevicular fluid samples in a noninvasive manner is provided. Once optimally positioned, an absorbing brush of the instrument is inserted into the gingival sulcus of a patient and held in place while the bristles of the absorbing brush absorb the gingival crevicular fluid. Once removed from the collection sight, the absorbing brush bristles can provide a visual indication of the presence of biomarkers and proteins associated with periodontitis.

Abstract: A steerable assembly comprises an elongated body structure with an implement arranged at a distal end thereof, wherein a premagnetized material is arranged closer to the distal end than a proximal end, and is configured to enable steering of the implement through tissue of an animal body responsive to application of a magnetic field eternal to the body. A method for guiding passage of an implement through tissue includes altering strength and/or position of at least one magnetic field source external to an animal body to interact with and effectuate movement of a premagnetized material inserted into the animal body.

Abstract: A compound selected from the group consisting of Formula I, Formula II, and Formula III, wherein ring A, ring B, and ring C are independently a five-membered or six-membered, carbocyclic or heterocyclic ring, each of which is optionally aromatic; ring W of Formula I is a 6-membered heterocyclic ring, and ring W of Formula II or Formula III is a 5-membered or 6-membered heterocyclic ring; L is a monodentate ligand with a metal coordinating member selected from the group consisting of C, N, O, S, and P; and M is a metal selected from the group consisting of Cu, Au, and Ag.

Abstract: An aspect of an embodiment or partial embodiment of the present invention (or combinations of various embodiments in whole or in part of the present invention) comprises, but not limited thereto, a method and system (and related computer program product) for continually assessing the risk of hypoglycemia for a patient and then determining what action to take based on that risk assessment. A further embodiment results in two outputs: (1) an attenuation factor to be applied to the insulin rate command sent to the pump (either via conventional therapy or via open or closed loop control) and/or (2) a red/yellow/green light hypoglycemia alarm providing to the patient an indication of the risk of hypoglycemia. The two outputs of the CPHS can be used in combination or individually.

Abstract: An emission driver includes stages. At least one of the stages has a carry control node outputting a carry signal and an emission control node outputting an emission signal that are separated. Further, a second low gate voltage may be used that may be lower that a first low gate voltage. Further, transistors between each of the carry and emission control nodes and a second low voltage line transferring the second low gate voltage may have a series two transistor structure. Further, a transistor outputting the second low gate voltage as the carry signal may be repeatedly turned on and off in response to an inverted low clock signal. Accordingly, operation reliability of the emission driver of the display device may be improved.

Abstract: Compositions are provided for efficient uranium extraction, for example from wastewater, seawater, or other water sources. The compositions can include a functionalized porous organic polymer functionalized with one or more uranium binding moieties, e.g. having a plurality of amidoxime or amidrazone groups covalently attached thereto. The compositions can include covalent organic frameworks, porous aromatic frameworks, and various porous organic polymers, especially those having a hierarchical pore size distribution over a range of pore sizes. The compositions can have functional groups such as amidoxime or an amidrazone covalently attached thereto. The hierarchical pore size distribution can be determined based upon at least 60% of the pore sizes in the range of pore sizes having a pore volume of at least 0.01 cm3 g?1 in the pore size distribution at 77 K. Methods of making the compositions and methods of using the compositions are also provided.

Abstract: Disclosed herein are compositions comprising a CT20 peptide and methods of using the disclosed compositions to treat cancers expressing chaperonin containing TCP (CCT).

Abstract: A novel tracing apparatus includes an electromagnetic transmitting system, a multi-frequency transmitting antenna, electrodes, and a receiver. The electromagnetic transmitting system is at an upstream point and includes a generator and a transmitter having a capacitor; the transmitting antenna penetrates into a detected aquifer through karst collapse or a drill hole; the electrodes and the receiver are at a downstream point, and include two pairs of electrodes orthogonally distributed and located in a cofferdam formed by downstream water; and the receivers collect electric signals in the electrodes. The apparatus is based on good electrical conductivity of water, and can use electromagnetic signals as a tracer for rapid observation. Compared with traditional tracers, electromagnetic signals propagate fast in water, are stable in property, and free of pollution.

Abstract: The present disclosure relates to methods of detecting gene expression in a biological sample from an animal. More specifically, this disclosure relates to methods of detecting risk for a catastrophic injury in an animal, such as a non-human athletic animal, based on the expression of select genes within a biological sample from the animal, which can be determined using mRNA expression analysis.

Abstract: The present disclosure provides an operation method of a PET (positron emission tomography) quantitative localization system, which includes steps as follows. The PET image and the MRI (magnetic resonance imaging) of the patient are acquired; the nonlinear deformation is performed on the MRI and the T1 template to generate deformation information parameters; the AAL (automated anatomical labeling) atlas is deformed to an individual brain space of the patient, so as to generate an individual brain space AAL atlas, where the AAL atlas and the T1 template are in a same space; lateralization indexes of the ROIs of the individual brain space AAL atlas corresponding to the PET image normalized through the gray-scale intensity are calculated; the lateralization indexes are inputted into one or more machine learning models to analyze the result of determining a target.

Abstract: The present disclosure discloses methods and apparatus for fatigue prediction based on analogue brain wave data, wherein one of the methods comprises: collecting an eye video sequence based on a video capture device; inputting the eye video sequence into a default fatigue discriminator to obtain predicted analogue brain wave data; and outputting the analogue brain wave data to a fatigue discriminant to discriminate a fatigue state. By adopting such a method for fatigue prediction based on analogue brain wave data described in the present disclosure, corresponding analogue brain wave data can be generated through acquiring eye image data, and the fatigue state can be predicted according to the analogue brain waves, so as to avoid tedious operation steps and improve the robustness and accuracy of the fatigue state detection, thereby greatly improving the user experience.

Abstract: A computational systems pathology spatial analysis platform includes: (i) a spatial heterogeneity quantification component configured for generating a global quantification of spatial heterogeneity among cells of varying phenotypes in multi-parameter cellular and subcellular imaging data; (ii) a microdomain identification component configured for identifying a plurality of microdomains for tissue samples based on the global quantification, each microdomain being associated with a tissue sample; and (iii) a weighted graph component configured for constructing a weighted graph for the multi-parameter cellular and subcellular imaging data, the weighted graph having a plurality of nodes and a plurality of edges each being located between a pair of the nodes, wherein in the weighted graph each node is a particular one of the microdomains and the edge between each pair of microdomains in the weighted graph is indicative of a degree of similarity between the pair of the microdomains.

Abstract: This disclosure relates to compositions and methods for selective labeling of N-alkyl lysine, N-alkyl adenosine, proline, N-alkyl cytosine, peptides, nucleic acids, or aliphatic or aromatic secondary amines. In certain embodiments, this disclosure relates to methods of forming triazene labeled compounds comprising contacting a compound containing a secondary amine group with a compound comprising an aromatic group with a diazonium para substituted with an electron rich group under conditions such that a triazene labeled compound is formed at the secondary amine group.

Abstract: A memtransistor includes a top gate electrode and a bottom gate electrode; a polycrystalline monolayer film formed of an atomically thin material disposed between the top gate electrode and the bottom gate electrode; and source and drain electrodes spatial-apart formed on the polycrystalline monolayer film to define a channel in the polycrystalline monolayer film between the source and drain electrodes. The top gate electrode and the bottom gate electrode are capacitively coupled with the channel.

Abstract: A back side of a diamond or other substrate is thinned using plasma etches and a mask situated away from the back side by a spacer having a thickness between 50 ?m and 250 ?m. Typically, a combined RIE/ICP etch is used to thin the substrate from 20-40 ?m to less than 1 ?m. For applications in which color centers are implanted or otherwise situated on a front side of the diamond substrate, after thinning, a soft graded etch is applied to reduce color center linewidth, particularly for nitrogen vacancy (NV) color centers.

Abstract: A 2-(benzo[d]thiazol-2-yl)-N?-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide compound, its synthesis, and its use as an antimicrobial agent.

Abstract: A 2-(benzo[d]oxazol-2-yl)-N?-(isonicotinoyloxy)acetimidamide compound, its synthesis, and its use as an antimicrobial agent.

Abstract: A nano-sized chitosan/VS2 nanocomposite for use in various pharmaceutical applications. The nano-sized chitosan/VS2 nanocomposite can be formed as a flower nanocomposite.

Abstract: The present disclosure provides a variable region sequence of a broad-spectrum antibody against clothianidin and dinotefuran, where a gene encoding a heavy chain variable region has an amino acid sequence shown in SEQ ID NO: 2. The present disclosure further discloses a broad-spectrum intact recombinant antibody against clothianidin and dinotefuran, including a heavy chain constant region, a heavy chain variable region, a light chain constant region, and a light chain variable region, where a gene encoding the heavy chain variable region has an amino acid sequence shown in SEQ ID NO: 2. The sequence genes obtained by the present disclosure are ligated to an expression vector containing a heavy chain constant region gene and a light chain constant region gene, respectively, and an intact recombinant antibody is expressed and obtained by using mammalian cells with a double-plasmid system.